133 related articles for article (PubMed ID: 2447612)
1. Radiotherapy using the hypoxic cell sensitizer Ro 03-8799 in malignant melanoma.
Dische S
Radiother Oncol; 1987 Oct; 10(2):111-6. PubMed ID: 2447612
[TBL] [Abstract][Full Text] [Related]
2. Radiosensitization by the combination of etanidazole (SR-2508) and pimonidazole (Ro 03-8799) in human tumor xenografts.
Taghian A; Lespinasse F; Guichard ME
Int J Radiat Oncol Biol Phys; 1991 Nov; 21(6):1535-40. PubMed ID: 1834621
[TBL] [Abstract][Full Text] [Related]
3. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.
Seegenschmiedt MH; Keilholz L; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):607-18. PubMed ID: 10348291
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitizing and cytocidal effects on hypoxic cells of RO-07-0582, and repair of x-ray injury, in an experimental mouse tumour.
Hill SA; Fowler JF
Br J Cancer; 1977 Apr; 35(4):461-9. PubMed ID: 869984
[TBL] [Abstract][Full Text] [Related]
5. Response rate of malignant melanoma to large fraction irradiation.
Adam JS; Habeshaw T; Kirk J
Br J Radiol; 1982 Aug; 55(656):605-7. PubMed ID: 6180791
[No Abstract] [Full Text] [Related]
6. The radiosensitizing effect of metronidazole and misonidazole (Ro-07-0582) on a human malignant melanoma grown in the athymic mutant nude mouse.
Rofstad EK; Brustad T
Br J Radiol; 1978 May; 51(605):381-6. PubMed ID: 638410
[TBL] [Abstract][Full Text] [Related]
7. Palliative radiotherapy of malignant melanoma with reactor fission neutron therapy (RENT): a prospective study.
Bremer M; Neuhofer C; Auberger T; Zimmermann FB; Kneschaurek P; Reuschel W; Molls M
Radiat Oncol Investig; 1999; 7(2):118-24. PubMed ID: 10333253
[TBL] [Abstract][Full Text] [Related]
8. The role of radiotherapy in the primary management of cutaneous melanoma.
Trotti A; Peters LJ
Ann Plast Surg; 1992 Jan; 28(1):39-44. PubMed ID: 1379419
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799.
Dische S; Saunders MI; Bennett MH; Dunphy EP; Des Rochers C; Stratford MR; Minchinton AI; Wardman P
Br J Radiol; 1986 Sep; 59(705):911-7. PubMed ID: 3756388
[TBL] [Abstract][Full Text] [Related]
10. Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours.
Thomlinson RH; Dische S; Gray AJ; Errington LM
Clin Radiol; 1976 Apr; 27(2):167-74. PubMed ID: 776494
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
12. Radiation therapy as an alternate therapy for locally recurrent acral lentiginous malignant melanoma.
Newman C; Wagner RF; Gordan W; Sanchez RL
Arch Dermatol; 1992 Jan; 128(1):19-21. PubMed ID: 1739284
[No Abstract] [Full Text] [Related]
13. The current status of drug development of hypoxic cell radiosensitizers and their potential role in gynecologic oncology.
Coleman CN; Ballon SC; Howes AE; Martinez A; Halsey J; Hirst VK
Gynecol Oncol; 1984 May; 18(1):18-27. PubMed ID: 6201419
[TBL] [Abstract][Full Text] [Related]
14. [The role of radiation therapy in the primary treatment of malignant melanoma].
Scherer E
Haematol Blood Transfus; 1978; 21():277-83. PubMed ID: 83952
[No Abstract] [Full Text] [Related]
15. Feasibility of Postoperative Radiotherapy Using Conventional Fractionation for Lymph Node Metastasis from Cutaneous Melanoma.
Kim YJ; Song SY; Kim W; Jeong SY; Choi W; Je HU; Lee JS; Choi EK
Anticancer Res; 2017 Aug; 37(8):4239-4246. PubMed ID: 28739713
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant postoperative radiotherapy for cutaneous melanoma.
Mendenhall WM; Amdur RJ; Morris CG; Kirwan J; Shaw C; Dziegielewski PT
Acta Oncol; 2017 Mar; 56(3):495-496. PubMed ID: 28256960
[No Abstract] [Full Text] [Related]
17. The uptake of the radiosensitizing compound Ro 03-8799 (Pimonidazole) in human tumors.
Dische S; Bennett MH; Orchard R; Stratford MR; Wardman P
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1089-92. PubMed ID: 2703388
[TBL] [Abstract][Full Text] [Related]
18. 0-7-21 radiotherapy in nodular melanoma.
Johanson CR; Harwood AR; Cummings BJ; Quirt I
Cancer; 1983 Jan; 51(2):226-32. PubMed ID: 6185198
[TBL] [Abstract][Full Text] [Related]
19. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
[TBL] [Abstract][Full Text] [Related]
20. Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology.
Overgaard J; Gonzalez Gonzalez D; Hulshof MC; Arcangeli G; Dahl O; Mella O; Bentzen SM
Lancet; 1995 Mar; 345(8949):540-3. PubMed ID: 7776772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
